Ask AI
ProCE Banner Activity

Unmet Needs, Mechanisms of Resistance, and Biomarker Testing in HR+/HER2- Advanced Breast Cancer Progressing on First-line CDK4/6 Inhibitor Plus Endocrine Therapy

Slideset

Downloadable slides on mechanisms of resistance and biomarker testing in HR+/HER2- advanced breast cancer progressing on first-line CDK4/6 inhibitor plus endocrine therapy.

Released: May 30, 2025

Expiration: November 29, 2025

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Lilly and Stemline Therapeutics, Inc.

AstraZeneca

Lilly

Stemline Therapeutics, Inc.